Under Armour Valuation
Is UAA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of UAA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: UAA * (MX$196) is trading above our estimate of fair value (MX$88.63)
Significantly Below Fair Value: UAA * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for UAA *?
Key metric: As UAA * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is UAA *'s PS Ratio? | |
---|---|
PS Ratio | 0.8x |
Sales | US$5.40b |
Market Cap | US$3.95b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.9x |
Enterprise Value/EBITDA | 13.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does UAA *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.6x | ||
BRBY Burberry Group | 1.2x | 1.9% | UK£3.2b |
6181 Laopu Gold | 5.6x | 24.6% | HK$31.9b |
KTB Kontoor Brands | 2x | 2.9% | US$5.0b |
COLM Columbia Sportswear | 1.5x | 4.6% | US$4.8b |
UAA * Under Armour | 0.8x | 1.9% | Mex$3.9b |
Price-To-Sales vs Peers: UAA * is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (2.4x).
Price to Sales Ratio vs Industry
How does UAA *'s PS Ratio compare vs other companies in the South American Luxury Industry?
4 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
4 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: UAA * is good value based on its Price-To-Sales Ratio (0.8x) compared to the South American Luxury industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is UAA *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.8x |
Fair PS Ratio | 1.3x |
Price-To-Sales vs Fair Ratio: UAA * is good value based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$196.00 | Mex$221.51 +13.0% | 24.0% | Mex$325.00 | Mex$81.25 | n/a | 19 |
Nov ’25 | Mex$172.00 | Mex$169.48 -1.5% | 25.9% | Mex$277.94 | Mex$79.41 | n/a | 19 |
Oct ’25 | Mex$175.85 | Mex$163.34 -7.1% | 24.6% | Mex$269.50 | Mex$77.00 | n/a | 20 |
Sep ’25 | Mex$148.50 | Mex$158.87 +7.0% | 24.1% | Mex$263.68 | Mex$75.34 | n/a | 20 |
Aug ’25 | Mex$127.00 | Mex$137.40 +8.2% | 28.2% | Mex$251.12 | Mex$71.75 | n/a | 20 |
Jul ’25 | Mex$120.00 | Mex$147.47 +22.9% | 25.6% | Mex$257.76 | Mex$110.47 | n/a | 21 |
Jun ’25 | Mex$121.00 | Mex$137.05 +13.3% | 27.3% | Mex$234.26 | Mex$100.40 | n/a | 21 |
May ’25 | Mex$114.90 | Mex$164.31 +43.0% | 24.2% | Mex$265.77 | Mex$120.03 | n/a | 23 |
Apr ’25 | Mex$121.92 | Mex$162.28 +33.1% | 23.7% | Mex$258.75 | Mex$116.86 | n/a | 24 |
Mar ’25 | Mex$151.00 | Mex$171.74 +13.7% | 22.1% | Mex$265.86 | Mex$137.22 | n/a | 24 |
Feb ’25 | Mex$132.19 | Mex$169.36 +28.1% | 22.1% | Mex$262.19 | Mex$135.32 | n/a | 24 |
Jan ’25 | Mex$154.00 | Mex$170.01 +10.4% | 22.1% | Mex$263.19 | Mex$135.84 | n/a | 24 |
Dec ’24 | Mex$145.00 | Mex$170.74 +17.8% | 21.8% | Mex$266.99 | Mex$137.80 | n/a | 24 |
Nov ’24 | Mex$121.00 | Mex$184.22 +52.2% | 24.0% | Mex$278.70 | Mex$107.89 | Mex$172.00 | 22 |
Oct ’24 | Mex$115.00 | Mex$175.67 +52.8% | 23.2% | Mex$264.59 | Mex$119.49 | Mex$175.85 | 22 |
Sep ’24 | Mex$133.00 | Mex$175.90 +32.3% | 23.7% | Mex$264.45 | Mex$119.43 | Mex$148.50 | 21 |
Aug ’24 | Mex$135.00 | Mex$175.22 +29.8% | 22.7% | Mex$261.03 | Mex$117.88 | Mex$127.00 | 21 |
Jul ’24 | Mex$124.00 | Mex$179.10 +44.4% | 21.7% | Mex$266.23 | Mex$120.23 | Mex$120.00 | 22 |
Jun ’24 | Mex$130.00 | Mex$187.42 +44.2% | 20.4% | Mex$272.08 | Mex$122.87 | Mex$121.00 | 22 |
May ’24 | Mex$159.80 | Mex$222.67 +39.3% | 16.7% | Mex$277.89 | Mex$161.36 | Mex$114.90 | 20 |
Apr ’24 | Mex$165.00 | Mex$226.54 +37.3% | 15.3% | Mex$279.35 | Mex$180.22 | Mex$121.92 | 20 |
Mar ’24 | Mex$179.50 | Mex$234.58 +30.7% | 14.3% | Mex$296.25 | Mex$185.16 | Mex$151.00 | 23 |
Feb ’24 | Mex$236.00 | Mex$225.70 -4.4% | 19.7% | Mex$297.94 | Mex$148.97 | Mex$132.19 | 24 |
Jan ’24 | Mex$186.00 | Mex$213.07 +14.6% | 22.1% | Mex$303.22 | Mex$156.50 | Mex$154.00 | 24 |
Dec ’23 | Mex$190.21 | Mex$210.35 +10.6% | 27.9% | Mex$386.25 | Mex$154.50 | Mex$145.00 | 24 |
Nov ’23 | Mex$150.00 | Mex$214.54 +43.0% | 30.2% | Mex$394.40 | Mex$128.18 | Mex$121.00 | 24 |
Analyst Forecast: Target price is less than 20% higher than the current share price.